Shanghai Pharmaceuticals Holding(601607.SH): Nicorandil tablets pass consistency evaluation.
Shanghai Pharmaceuticals (601607.SH) announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. (referred to as "Shandong Xinyi"...
Shanghai Pharmaceuticals Holding announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. ("Shandong Xinyi") received the "Notification of Approval for Drug Supplementary Application" issued by the National Medical Products Administration. The drug, Nicardipine Tablets, has passed the generic drug quality and efficacy consistency evaluation. Nicardipine tablets are used for the treatment of angina.
Related Articles

TRULY INT'L (00732) spent 868,000 Hong Kong dollars to repurchase 724,000 shares on September 18th.

HAOHAI BIOTEC (06826) spent 649,200 HKD to repurchase 23,500 shares on September 18.

MEDIA CHINESE (00685) repurchased 50,000 shares on September 18.
TRULY INT'L (00732) spent 868,000 Hong Kong dollars to repurchase 724,000 shares on September 18th.

HAOHAI BIOTEC (06826) spent 649,200 HKD to repurchase 23,500 shares on September 18.

MEDIA CHINESE (00685) repurchased 50,000 shares on September 18.
